Farmak JSC has introduced L’esfal hepatoprotector to the market

Farmak’s specialists have developed L’esfal hepatoprotective drug of broad use spectrum an...

Jan 25, 2013

Farmak JSC has improved the formula of Injesta ampoule progesterone

Farmak’s specialists have improved the formula of Injesta ampoule progesterone. The improv...

Jan 17, 2013

Farmak JSC has developed the drug to treat arterial hypertension called Ramizes ...

Farmak JSC has developed and launched into the market the arterial hypertension drug for t...

Jan 11, 2013

Farmak’s Employees Help the Orphaned Children

In December, 2012 Farmak’s employees participated in the charity campaign. They gathered t...

Dec 21, 2012

The name of the dermatological drug Mometasone was changed to Moleskin

Farmak has changed the name of Mometasone (active ingredient: mometasone furoate), a drug ...

Dec 18, 2012

Name of the glaucoma treatment drug Timolol was changed to Oftimol

Farmak has changed the name of the anti-glaucoma drug Timolol (active ingredient: Timolol ...

Dec 04, 2012

Farmak JSC defends the right to manufacture Chondrasil

Farmak JSC, the leading pharmaceutical company in Ukraine, has defended the right to manuf...

Nov 27, 2012

The Pectolvan line of cough medicine now features a new Pectolvan Phyto form

Pectolvan Phyto, a universal cough medicine for adults is now available in two volumes: 25...

Nov 26, 2012

Tropicamide now requires name-specific and quantitative accounting

Drugs marketed under international unpatented name Tropicamide are now listed as medicatio...

Nov 20, 2012
Show more